Last reviewed · How we verify

NCT05137743: GWAIR

Pilot Test of Apnea and Insomnia Relief for Veterans With Gulf War Illness

Active, enrolled NA Last updated 9 February 2026
What this trial tests

NA trial testing Apnea and Insomnia Relief (AIR) in Gulf War Illness in 80 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
15 February 2022
Primary endpoint
31 March 2026
31 July 2026

Quick facts

Lead sponsorUniversity of California, San Francisco
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment80
Start date15 February 2022
Primary completion31 March 2026
Estimated completion31 July 2026
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of California, San Francisco

Who can join

Adults 48 to 80, any sex, with Gulf War Illness. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to determine whether a behavioral sleep treatment improves sleep and other Gulf War Illness (GWI) symptoms in Gulf War Veterans with GWI.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Apnea and Insomnia Relief (AIR)

Trials testing the same drug.

Other recruiting trials for Gulf War Illness

Currently open trials in the same condition.

Other University of California, San Francisco trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05137743.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing